Dr. Joo Y. Song, MD

Dr. Song practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Song's NPI, 1275856619, was assigned on March 11, 2010. Dr. Song graduated from George Washington University School of Medicine and Health Sciences in 2005. Dr. Song holds California license A114897.

Dr. Song's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Song's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dr. Song is also affiliated with Pomona Valley Hospital Medical Center. The medical group on file is City of Hope. Dmand AI also links Dr. Song to 2 more hospitals and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Song practices, 4 sites in all. Vendor and product names are available with a free account.

Anatomic pathology and clinical pathology is Dr. Song's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Dr. Song is board certified in hematopathology by the American Board of Pathology. Dmand AI has Dr. Song's licenses on file in 2 states: California and District of Columbia.

CMS data shows 2,793 Medicare services from Dr. Song across 21 procedure codes in 2024, for 729 Medicare patients. Medicare paid $77,093 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 729 Medicare patients who saw Dr. Song in 2024. The largest group is 65 to 74, with 361 patients. 73% of them have high blood pressure, and 68% have high cholesterol. 26% are also on Medicaid. Their average risk score is 3.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Song's median patient age at 67, with 48% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Song for performance year 2024, reported as part of a group. Dr. Song accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 105 papers to Dr. Song, published from 2008 to 2025. 2021 was the busiest year, with 12. The most frequent topics are Lymphoma, Large B-Cell, Diffuse, Antineoplastic Combined Chemotherapy Protocols and Lymphoma, T-Cell, Peripheral. Dr. Song has published most often in Blood. Dr. Song's most frequent co-authors are Wing C. Chan, MD, Dennis D. Weisenburger, MD and Stephen J. Forman, MD.

CMS Open Payments shows 7 general payments to Dr. Song from 3 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 66% of the total. Seagen Inc. paid the most, $1,224.

Dr. Song graduated from George Washington University School of Medicine and Health Sciences in 2005. Dr. Song is a member of ASH.

Dr. Song is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.